Corporate Responsibility And Public Benefit Report

Overview

The report describes United Therapeutics' 2023 progress in organ manufacturing, patient service, workforce growth, and sustainable operations. Highlights include the Miromatrix and IVIVA acquisitions, 1,168 employees across 13 locations, LEED Gold certification for a warehouse, and almost 7-MW of onsite solar capacity. The report also explains that Scope 1 and Scope 2 emissions data were being prepared for disclosure, while broader climate-risk and Scope 3 reporting remained under development.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 12 September 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services